This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Coagulation and haemorrhagic disorders
  • /
  • Acquired hypofibrinogenemia: current perspectives.

Acquired hypofibrinogenemia: current perspectives.

Read time: 1 mins
Published:25th Sep 2016
Author: Besser MW, MacDonald SG.
Availability: Free full text
Ref.:J Blood Med. 2016;7:217-225. eCollection 2016.

Acquired hypofibrinogenemia is most frequently caused by hemodilution and consumption of clotting factors. The aggressive replacement of fibrinogen has become one of the core principles of modern management of massive hemorrhage. The best method for determining the patient's fibrinogen level remains controversial, and particularly in acquired dysfibrinogenemia, could have major therapeutic implications depending on which quantification method is chosen.

This review introduces the available laboratory and point-of-care methods and discusses the relative advantages and limitations. It also discusses current strategies for the correction of hypofibrinogenemia.


Read abstract on library site

Access full article